Nasopharynx Cancer Whole Exome Sequencing
Demographics (2)
- Age - Participant's age in years (phv00278013.v1.p1)
- Sex - Participant's gender as male or female (phv00278014.v1.p1)
Disease Events (10)
- Disease Free Survival - Length of time after primary treatment ends that the participant survives without signs or symptoms of disease (phv00278023.v1.p1)
- Family History - Familial history of disease (phv00278017.v1.p1)
- Lymph node (N) - Stage of lymph nodes by TNM system (phv00278019.v1.p1)
- Metastasis (M) - Stage of metastasis by TNM system (phv00278020.v1.p1)
- Overal Survival - Length of time after diagnosis or start of treatment that the participant is alive (phv00278024.v1.p1)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00278026.v1.p1)
- Status - Life status of participant (phv00278022.v1.p1)
- Treatment - Primary treatment administered to participant (phv00278021.v1.p1)
- Tumor (T) - Stage of primary tumor by TNM system (phv00278018.v1.p1)
- Tumor Type - Indicates primary, metastatic, or recurrent tumor and tissue site if not nasopharynx (phv00278027.v1.p1)
Substance Use (2)
- Drinking - Drinking history (phv00278016.v1.p1)
- Smoking - Smoking history (phv00278015.v1.p1)
Other (8)
- ANALYTE_Type - Molecular analyte (phv00278028.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00278008.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00278025.v1.p1)
- SAMPLE_ID - Sample ID (phv00278010.v1.p1)
- SAMPLE_USE - Sample Use (phv00278011.v1.p1)
- SUBJECT_ID - Unique participant identifier (phv00278012.v1.p1)
- SUBJECT_ID - Subject ID (phv00278009.v1.p1)
- SUBJECT_ID - Subject ID (phv00278007.v1.p1)